Entera Bio (ENTX) Receivables (2018 - 2025)

Entera Bio (ENTX) recorded quarterly Receivables of $126000.0 in Q1 2025, little changed on a QoQ basis from $126000.0 in Q4 2024.

Entera Bio (ENTX) Receivables (2018 - 2025) Analysis & Trends

Entera Bio has disclosed Receivables across 7 years of filings, most recently posting $126000.0 for Q1 2025.

  • Quarterly Receivables changed N/A year-over-year to $126000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $126000.0 (changed N/A YoY) and the FY2024 annual result came in at $126000.0, changed N/A from the prior year.
  • Receivables steadied at $126000.0 in Q1 2025, from $126000.0 in the prior quarter.
  • Over five years, Receivables peaked at $246000.0 in Q4 2022 and troughed at $29000.0 in Q1 2023.
  • A 5-year average of $136909.1 and a median of $126000.0 in 2024 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2023 — Receivables slumped 87.11% — and 2024, when it jumped 96.55%.
  • Tracing ENTX's Receivables over 5 years: stood at $183000.0 in 2021, then jumped by 34.43% to $246000.0 in 2022, then plunged by 88.21% to $29000.0 in 2023, then soared by 334.48% to $126000.0 in 2024, then changed by 0.0% to $126000.0 in 2025.
  • Business Quant data shows ENTX's Receivables at $126000.0 in Q1 2025, $126000.0 in Q4 2024, and $42000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 13.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 2.00 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Entera Bio 56.59 Mn 52.45 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 126,000.00
Dec 31, 2024 126,000.00
Sep 30, 2024 42,000.00
Jun 30, 2024 57,000.00
Jun 30, 2023 29,000.00
Mar 31, 2023 29,000.00
Dec 31, 2022 246,000.00
Sep 30, 2022 233,000.00
Jun 30, 2022 225,000.00
Mar 31, 2022 210,000.00
Dec 31, 2021 183,000.00
Dec 31, 2020 255,000.00
Dec 31, 2018 1.56 Mn